Emily Field, Barclays head of European pharmaceutical research, joins Squawk Box to discuss the state of the weight loss drug market, disappointing







CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field [CD4C_CMbYTr]

CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field [CD4C_CMbYTr]

| 1h 28m 28s | Video has closed captioning.

Emily Field, Barclays head of European pharmaceutical research, joins 'Squawk Box' to discuss the state of the weight loss drug market, disappointing trial results of Novo Nordisk's experimental CagriSema weight loss drug, and more. #keto ultra diet pills review #are keto gummies a sham

Aired: January 06, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field [CD4C_CMbYTr] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field [CD4C_CMbYTr] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field [CD4C_CMbYTr] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now